During a @-week extension period , subjects were up-titrated from @ mg pitavastatin to a maximum dose of @ mg in an effort to achieve an optimum low-density lipoprotein cholesterol ( LDL-C ) treatment target of < @ mg/dL ( @ mmol/L ) .